GALAPAGOS
GALAPAGOS NV, commonly referred to as Galapagos, is a pioneering biotechnology company headquartered in the United States, with significant operations in Europe. Founded in 1999, Galapagos has established itself in the pharmaceutical industry, focusing on the discovery and development of innovative medicines for various diseases, including inflammatory and fibrotic conditions. The company is renowned for its unique drug discovery platform, which leverages advanced technologies to identify and develop novel therapeutic candidates. Notable achievements include the successful development of several clinical-stage programmes, positioning Galapagos as a leader in the biopharmaceutical sector. With a commitment to scientific excellence and a robust pipeline, Galapagos continues to make significant strides in transforming patient care through groundbreaking therapies.
DitchCarbon Score
How does GALAPAGOS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GALAPAGOS's score of 36 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
GALAPAGOS's reported carbon emissions
In 2023, GALAPAGOS reported total carbon emissions of approximately 36,537,000 kg CO2e, a significant reduction from about 54,609,000 kg CO2e in 2022. The emissions breakdown for 2023 includes Scope 1 emissions of about 2,922,000 kg CO2e, Scope 2 emissions of approximately 1,132,000 kg CO2e (with a market-based total of about 173,000 kg CO2e), and Scope 3 emissions of around 36,537,000 kg CO2e. The Scope 3 emissions are further detailed, with major contributions from purchased goods and services (approximately 28,257,000 kg CO2e) and business travel (about 1,480,000 kg CO2e). Despite these figures, GALAPAGOS has not established specific reduction targets or climate pledges, indicating a potential area for future commitment in their sustainability strategy. The company operates within a global context, where addressing carbon emissions is increasingly critical for corporate responsibility and environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 3,180,000 | 0,000,000 |
| Scope 2 | 217,000 | 000,000 |
| Scope 3 | 54,609,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GALAPAGOS is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
